-
1
-
-
85083291608
-
-
Accessed 12 Apr 2020
-
World Health Organization (WHO). https://www.who.int/. Accessed 12 Apr 2020.
-
-
-
-
2
-
-
85079629819
-
COVID-19: Fighting panic with information
-
10224.The Lancet 10.1016/S0140-6736(20)30379-2 1:STN:280:DC%2BB387ltVOmsA%3D%3D 32087777 7138040
-
The Lancet. COVID-19: fighting panic with information. Lancet. 2020;395(10224):537. https://doi.org/10.1016/S0140-6736(20)30379-2.
-
(2020)
Lancet
, vol.395
, pp. 537
-
-
-
3
-
-
85080979717
-
Open access epidemiological data from the COVID-19 outbreak.
-
Xu B, Kraemer MUG, Xu B, et al. Open access epidemiological data from the COVID-19 outbreak. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30119-5.
-
(2020)
Lancet Infect Dis.
-
-
Xu, B.1
Kraemer, M.U.G.2
Xu, B.3
-
4
-
-
85018454702
-
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: A perspective from COMBACTE's STAT-net
-
10.1007/s00134-017-4802-4 28466147 5487537
-
Timsit J-F, de Kraker MEA, Sommer H, et al. Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-net. Intensive Care Med. 2017;43(7):1002-12. https://doi.org/10.1007/s00134-017-4802-4.
-
(2017)
Intensive Care Med
, vol.43
, Issue.7
, pp. 1002-1012
-
-
Timsit, J.-F.1
De Kraker, M.E.A.2
Sommer, H.3
-
5
-
-
84894076536
-
Avoidable statistical pitfalls in analyzing length of stay in intensive care units or hospitals
-
Wolkewitz M. Avoidable statistical pitfalls in analyzing length of stay in intensive care units or hospitals. Crit Care. 2014;18(1):408.
-
(2014)
Crit Care
, vol.18
, Issue.1
, pp. 408
-
-
Wolkewitz, M.1
-
6
-
-
85014224818
-
Survival biases lead to flawed conclusions in observational treatment studies of influenza patients
-
10.1016/j.jclinepi.2017.01.008 28188897
-
Wolkewitz M, Schumacher M. Survival biases lead to flawed conclusions in observational treatment studies of influenza patients. J Clin Epidemiol. 2017;84:121-9. https://doi.org/10.1016/j.jclinepi.2017.01.008.
-
(2017)
J Clin Epidemiol
, vol.84
, pp. 121-129
-
-
Wolkewitz, M.1
Schumacher, M.2
-
7
-
-
84866853131
-
Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias
-
Wolkewitz M, Allignol A, Harbarth S, de Angelis G, Schumacher M, Beyersmann J. Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol. 2012;65(11):1171-80.
-
(2012)
J Clin Epidemiol
, vol.65
, Issue.11
, pp. 1171-1180
-
-
Wolkewitz, M.1
Allignol, A.2
Harbarth, S.3
De Angelis, G.4
Schumacher, M.5
Beyersmann, J.6
-
8
-
-
84907305181
-
Interpreting and comparing risks in the presence of competing events
-
Wolkewitz M, Cooper BS, Bonten MJ, Barnett AG, Schumacher M. Interpreting and comparing risks in the presence of competing events. BMJ. 2014;349:g5060.
-
(2014)
BMJ.
, vol.349
, pp. g5060
-
-
Wolkewitz, M.1
Cooper, B.S.2
Bonten, M.J.3
Barnett, A.G.4
Schumacher, M.5
-
9
-
-
33749019488
-
SARS: Systematic review of treatment effects. Low D, ed
-
10.1371/journal.pmed.0030343 1:CAS:528:DC%2BD28XhtV2iu7zF 16968120 1564166
-
Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. Low D, ed. PLoS Med. 2006;3(9):e343. https://doi.org/10.1371/journal.pmed.0030343.
-
(2006)
PLoS Med
, vol.3
, Issue.9
, pp. e343
-
-
Stockman, L.J.1
Bellamy, R.2
Garner, P.3
-
10
-
-
85079756319
-
Covid-19: A puzzle with many missing pieces
-
10.1136/bmj.m627
-
Vetter P, Eckerle I, Kaiser L. Covid-19: a puzzle with many missing pieces. BMJ. 2020;1:m627. https://doi.org/10.1136/bmj.m627.
-
(2020)
BMJ
, vol.1
, pp. m627
-
-
Vetter, P.1
Eckerle, I.2
Kaiser, L.3
-
11
-
-
85079618761
-
Reducing mortality from 2019-nCoV: Host-directed therapies should be an option
-
10224,10.1016/S0140-6736(20)30305-6 1:CAS:528:DC%2BB3cXisFagtro%3D 32035018 7133595
-
Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020;395(10224):e35-6. https://doi.org/10.1016/S0140-6736(20)30305-6.
-
(2020)
Lancet
, vol.395
, pp. e35-e36
-
-
Zumla, A.1
Hui, D.S.2
Azhar, E.I.3
Memish, Z.A.4
Maeurer, M.5
-
12
-
-
85079226451
-
2019 novel coronavirus-important information for clinicians.
-
del Rio C, Malani PN. 2019 novel coronavirus-important information for clinicians. JAMA. 2020. https://doi.org/10.1001/jama.2020.1490.
-
(2020)
JAMA.
-
-
Del Rio, C.1
Malani, P.N.2
-
13
-
-
85077715855
-
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
-
Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11. https://doi.org/10.1038/s41467-019-13940-6.
-
(2020)
Nat Commun.
, pp. 11
-
-
Sheahan, T.P.1
Sims, A.C.2
Leist, S.R.3
-
14
-
-
85079056243
-
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
-
10.1016/S0140-6736(20)30317-2 1:CAS:528:DC%2BB3cXisFaksr4%3D 32043983 7134694,10223
-
Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473-5. https://doi.org/10.1016/S0140-6736(20)30317-2.
-
(2020)
Lancet
, vol.395
, pp. 473-475
-
-
Russell, C.D.1
Millar, J.E.2
Baillie, J.K.3
-
15
-
-
85079793129
-
On the use of corticosteroids for 2019-nCoV pneumonia
-
10.1016/S0140-6736(20)30361-5 1:CAS:528:DC%2BB3cXjtVarsbY%3D 32122468,10225
-
Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395(10225):683-4. https://doi.org/10.1016/S0140-6736(20)30361-5.
-
(2020)
Lancet
, vol.395
, pp. 683-684
-
-
Shang, L.1
Zhao, J.2
Hu, Y.3
Du, R.4
Cao, B.5
-
16
-
-
85080101669
-
Severe SARS-CoV-2 infections: Practical considerations and management strategy for intensivists.
-
February
-
Bouadma L, Lescure F-X, Lucet J-C, Yazdanpanah Y, Timsit J-F. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. February 2020. https://doi.org/10.1007/s00134-020-05967-x.
-
(2020)
Intensive Care Med.
-
-
Bouadma, L.1
Lescure, F.-X.2
Lucet, J.-C.3
Yazdanpanah, Y.4
Timsit, J.-F.5
-
17
-
-
85079841872
-
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study.
-
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5.
-
(2020)
Lancet Respir Med.
-
-
Yang, X.1
Yu, Y.2
Xu, J.3
-
18
-
-
85079760608
-
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series
-
10.1136/bmj.m606
-
Xu X-W, Wu X-X, Jiang X-G, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;1:m606. https://doi.org/10.1136/bmj.m606.
-
(2020)
BMJ
, vol.1
, pp. m606
-
-
Xu, X.-W.1
Wu, X.-X.2
Jiang, X.-G.3
-
19
-
-
85078761741
-
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study
-
10.1016/S0140-6736(20)30211-7 1:CAS:528:DC%2BB3cXhvFOmsb8%3D 32007143 32007143,10223
-
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/S0140-6736(20)30211-7.
-
(2020)
Lancet
, vol.395
, pp. 507-513
-
-
Chen, N.1
Zhou, M.2
Dong, X.3
-
20
-
-
85081214652
-
Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore.
-
Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020. https://doi.org/10.1001/jama.2020.3204.
-
(2020)
JAMA.
-
-
Young, B.E.1
Ong, S.W.X.2
Kalimuddin, S.3
-
21
-
-
85078262578
-
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
-
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30183-5.
-
(2020)
Lancet.
-
-
Huang, C.1
Wang, Y.2
Li, X.3
-
22
-
-
85079242706
-
Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.
-
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585.
-
(2020)
JAMA.
-
-
Wang, D.1
Hu, B.2
Hu, C.3
-
23
-
-
85083241171
-
Clinical characteristics of coronavirus disease 2019 in China.
-
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032.
-
(2020)
New Engl J Med.
-
-
Guan, W.1
Ni, Z.2
Hu, Y.3
-
24
-
-
85083545281
-
Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: A multicenter observational study.
-
Arabi YM, Shalhoub S, Mandourah Y, et al. Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: a multicenter observational study. Clin Infect Dis. https://doi.org/10.1093/cid/ciz544.
-
Clin Infect Dis.
-
-
Arabi, Y.M.1
Shalhoub, S.2
Mandourah, Y.3
-
25
-
-
85045205939
-
Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome
-
10.1164/rccm.201706-1172OC 29161116
-
Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med. 2018;197(6):757-67. https://doi.org/10.1164/rccm.201706-1172OC.
-
(2018)
Am J Respir Crit Care Med
, vol.197
, Issue.6
, pp. 757-767
-
-
Arabi, Y.M.1
Mandourah, Y.2
Al-Hameed, F.3
-
26
-
-
84977537867
-
The influence of corticosteroid treatment on the outcome of influenza a(H1N1pdm09)-related critical illness.
-
Delaney JW, Pinto R, Long J, et al. The influence of corticosteroid treatment on the outcome of influenza a(H1N1pdm09)-related critical illness. Crit Care. 2016;20. https://doi.org/10.1186/s13054-016-1230-8.
-
(2016)
Crit Care.
, pp. 20
-
-
Delaney, J.W.1
Pinto, R.2
Long, J.3
-
27
-
-
84897142275
-
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza a H1N1pdm09 virus infection: A meta-analysis of individual participant data
-
1:CAS:528:DC%2BC2cXhtFWisLjJ
-
Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza a H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395-404.
-
(2014)
Lancet Respir Med
, vol.2
, Issue.5
, pp. 395-404
-
-
Muthuri, S.G.1
Venkatesan, S.2
Myles, P.R.3
-
28
-
-
85082474264
-
A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19.
-
Cao B, Wang Y, Wen D, et al. A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19. New Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001282.
-
(2020)
New Engl J Med.
-
-
Cao, B.1
Wang, Y.2
Wen, D.3
-
29
-
-
85083291108
-
-
Accessed 4 Mar 2020
-
Global research on coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov. Accessed 4 Mar 2020.
-
Global Research on Coronavirus Disease (COVID-19).
-
-
-
30
-
-
85064665026
-
Following Cochrane review protocols to completion 10 years later: A retrospective cohort study and author survey
-
10.1016/j.jclinepi.2019.03.006 30928507
-
Runjic E, Behmen D, Pieper D, et al. Following Cochrane review protocols to completion 10 years later: a retrospective cohort study and author survey. J Clin Epidemiol. 2019;111:41-8. https://doi.org/10.1016/j.jclinepi.2019.03.006.
-
(2019)
J Clin Epidemiol
, vol.111
, pp. 41-48
-
-
Runjic, E.1
Behmen, D.2
Pieper, D.3
-
31
-
-
85072851985
-
Half of systematic reviews about pain registered in PROSPERO were not published and the majority had inaccurate status
-
10.1016/j.jclinepi.2019.08.010 31476376
-
Runjic E, Rombey T, Pieper D, Puljak L. Half of systematic reviews about pain registered in PROSPERO were not published and the majority had inaccurate status. J Clin Epidemiol. 2019;116:114-21. https://doi.org/10.1016/j.jclinepi.2019.08.010.
-
(2019)
J Clin Epidemiol
, vol.116
, pp. 114-121
-
-
Runjic, E.1
Rombey, T.2
Pieper, D.3
Puljak, L.4
-
32
-
-
85060921095
-
Knowledge synthesis in evidence-based medicine
-
10.1053/j.semnuclmed.2018.11.006 1:STN:280:DC%2BB3cfovFOktw%3D%3D 30819393
-
Garritty C, Stevens A, Hamel C, Golfam M, Hutton B, Wolfe D. Knowledge synthesis in evidence-based medicine. Semin Nucl Med. 2019;49(2):136-44. https://doi.org/10.1053/j.semnuclmed.2018.11.006.
-
(2019)
Semin Nucl Med
, vol.49
, Issue.2
, pp. 136-144
-
-
Garritty, C.1
Stevens, A.2
Hamel, C.3
Golfam, M.4
Hutton, B.5
Wolfe, D.6
-
33
-
-
85067131976
-
A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot
-
10.1186/s12916-019-1338-1 31185979 6560772
-
Sigfrid L, Moore C, Salam AP, et al. A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot. BMC Med. 2019;17(1):107. https://doi.org/10.1186/s12916-019-1338-1.
-
(2019)
BMC Med
, vol.17
, Issue.1
, pp. 107
-
-
Sigfrid, L.1
Moore, C.2
Salam, A.P.3
-
34
-
-
84968756815
-
Quality of conduct and reporting in rapid reviews: An exploration of compliance with PRISMA and AMSTAR guidelines
-
10.1186/s13643-016-0258-9 27160255 4862155
-
Kelly SE, Moher D, Clifford TJ. Quality of conduct and reporting in rapid reviews: an exploration of compliance with PRISMA and AMSTAR guidelines. Syst Rev. 2016;5:79. https://doi.org/10.1186/s13643-016-0258-9.
-
(2016)
Syst Rev
, vol.5
, pp. 79
-
-
Kelly, S.E.1
Moher, D.2
Clifford, T.J.3
-
35
-
-
84961291709
-
Developing global norms for sharing data and results during public health emergencies
-
10.1371/journal.pmed.1001935 26731342 4701443
-
Modjarrad K, Moorthy VS, Millett P, Gsell P-S, Roth C, Kieny M-P. Developing global norms for sharing data and results during public health emergencies. PLoS Med. 2016;13(1):e1001935. https://doi.org/10.1371/journal.pmed.1001935.
-
(2016)
PLoS Med
, vol.13
, Issue.1
, pp. e1001935
-
-
Modjarrad, K.1
Moorthy, V.S.2
Millett, P.3
Gsell, P.-S.4
Roth, C.5
Kieny, M.-P.6
|